JAK2 and breast carcinoma: IL-6 expression is a critical step of breast cancer metastasis, leading to the activation of the JAK2/STAT3 signaling pathway that promotes proliferation, invasion, metastasis, and angiogenesis and inhibits apoptosis in breast cancers.